WHO Drug Information Vol. 17, No. 2, 2003
(2003; 64 pages) View the PDF document
Table of Contents
Open this folder and view contentsGood Manufacturing Practices
Open this folder and view contentsPersonal Perspectives
Open this folder and view contentsSafety Issues
Close this folderCurrent Topics
View the documentNew network for guideline development
View the documentFake artesunate tablets circulating again
View the documentEuropean Union enlargement: observers to EMEA
View the documentClinical cancer research review
View the documentNew foundation will develop tests for infectious diseases
View the documentTDR research training in 2004
View the documentManaging drug supply for primary health care
View the documentLatin American pharmacotherapy course
Open this folder and view contentsRegulatory and Safety Action
Open this folder and view contentsAspects of Quality Assurance
Open this folder and view contentsRecent Publications and Sources of Information
View the documentInternational Nonproprietary Names for Pharmaceutical Substances (INN)
 

New network for guideline development

The World Health Organization has become a founding member of the new Guidelines International Network (GIN). This is a major new international collaboration involving organizations from around the world. GIN seeks to improve the quality of health care by promoting systematic development of clinical practice guidelines and their application into practice. GIN’s aims are:

• To facilitate information sharing, education and knowledge transfer, and collaborative working between guideline programmes to promote best practice and avoid duplication of effort.

• To improve and harmonize methodologies for systematic guideline development in existing and new guideline programmes.

• To improve methodologies for dissemination and implementation of clinical practice guidelines and evaluation of their effects.

• To identify priorities for and support research relating to guideline development, dissemination, implementation, and evaluation; and to facilitate the application of research findings into practice.

• To build links between organizations to improve coordination with other health care quality initiatives.


So far, about forty organizations dealing with guideline development and quality of care from Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, New Zealand, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland, United Kingdom and USA have become founding members, at EUR 2500 per year.

WHO has become a founding member with the aim of representing the global perspective, and especially the developing country perspective. WHO has also negotiated a limited number of subsidized GIN memberships for organizations from developing countries.

Reference: Guidelines International Network, PO Box 13163, Duns, TD11 3YT, UK. Tel: +44.1361.884012, Fax: +44.1361.884013 e-mail: info@guidelinesinternational.net. http://www.guidelines-international.net

to previous section to next section
 

Last updated: May 3, 2013